Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ShIP: PRP vs Methylprednisolone for Shoulder Impingement
NCT02669303Terminated
- Sponsor
- American University of Beirut Medical Center
- Start
- Sep 2015
- Primary completion
- Jan 2017
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised, single-blind trial of platelet-rich plasma in shoulder impingement syndrome (SIS), sponsored by American University of Beirut Medical Center. Primary endpoint: Constant-Murley Total at 6 months. Started Sep 2015; status: terminated.
02
Drugs
platelet-rich plasma
03
Conditions
shoulder impingement syndrome (SIS)
Beyond the preview
Go deeper on NCT02669303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669303.